Sirnaomics Ltd. (2257.HK)
2257.HK Stock Price Chart
Explore Sirnaomics Ltd. interactive price chart. Choose custom timeframes to analyze 2257.HK price movements and trends.
2257.HK Company Profile
Discover essential business fundamentals and corporate details for Sirnaomics Ltd. (2257.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Dec 2021
Employees
69.00
Website
https://www.sirnaomics.comCEO
Hung Fai Poon
Description
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, focuses on the discovery and development of product candidates for indications with medical needs in the United Sates and the People's Republic of China. Its lead product candidates include STP705 for the treatment cutaneous squamous cell carcinoma in situ; basal cell carcinoma; cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; keloid scarless healing, hypertrophic scarring, and fat sculpting. The company's lead product candidates also comprise STP707 to treat cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; metastatic cutaneous squamous cell carcinoma; non-small cell lung cancer; liver fibrosis; and lung fibrosis. It also develops STP355 for the treatment of pan cancer; STP369 to treat head and neck/bladder cancer; STP779 for the treatment of liver/lung/pancreatic cancer; STP902 to treat breast cancer; STP702 for the treatment of influenza; STP908 to treat COVID-19; RIM730 COVID-19 vaccine; STP909 for the treatment of HPV/cervical cancer; and STP122G for thrombotic disorders. In addition, the company is developing STP125G to treat hypertriglyceridemia; STP144G for the treatment of complement-mediated diseases; STP133G for cardiometabolic; and STP155G for the treatment hepatitis B virus. Sirnaomics Ltd. was founded in 2007 and is headquartered in Gaithersburg, Maryland.
2257.HK Financial Timeline
Browse a chronological timeline of Sirnaomics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2024
EPS came in at -$0.51 , while revenue for the quarter reached $3.37M .
Earnings released on 30 Sept 2024
EPS came in at -$0.51 , while revenue for the quarter reached $3.37M .
Earnings released on 30 Jun 2024
EPS came in at -$2.11 , while revenue for the quarter reached $3.55M .
Earnings released on 31 Mar 2024
EPS came in at -$2.11 , while revenue for the quarter reached $3.56M .
Earnings released on 31 Dec 2023
EPS came in at -$2.02 , while revenue for the quarter reached $3.10M .
Earnings released on 31 Dec 2023
EPS came in at -$2.02 , while revenue for the quarter reached $3.10M .
Earnings released on 31 Dec 2023
EPS came in at -$2.10 , while revenue for the quarter reached $655.95K .
Earnings released on 31 Aug 2023
EPS came in at -$3.92 , while revenue for the quarter reached $3.10M .
Earnings released on 28 Mar 2023
EPS came in at -$2.27 , while revenue for the quarter reached $5.50M .
Earnings released on 31 Dec 2022
EPS came in at -$2.27 , while revenue for the quarter reached $5.50M .
Earnings released on 31 Aug 2022
EPS came in at -$4.32 .
Earnings released on 31 Mar 2022
EPS came in at -$14.61 .
Earnings released on 31 Dec 2021
EPS came in at -$27.88 , while revenue for the quarter reached $553.61K .
Earnings released on 20 Dec 2021
Earnings released on 31 Dec 2020
EPS came in at -$0.96 .
2257.HK Stock Performance
Access detailed 2257.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.